Few studies have referred to the implication of apoptotic processes followi
ng hormonal treatment. No data are available on the effects of progesterone
in breast cells. In order to gain insights on the effects of the gonadal s
teroids and antiestrogens in breast cells, we have carried out studies on a
poptosis in different breast materials. We have developed a model of normal
breast cells in cultures that remain hormone-dependent. On these cells and
in some hormone-dependent breast cancer cell lines (T-47-D, ZR75-1, MCF-7)
we have observed an antiapoptotic effect of estradiol (E-2) and a potent p
roapoptotic effect of some antiestrogens. Progestins were also proapoptotic
in normal as well as in hormone-dependent breast cancer cells. In order to
understand the mechanisms of these hormones on apoptosis, we studied the b
cl-2 family proteins, We demonstrated that E-2 increased the antiapoptotic
proteins, bcl-2 and bclx(L), whereas, the progestins drastically decreased
bcl-2 expression and weakly bclx(L) levels. We investigated the mechanisms
by which E-2 increased bcl-2 expression Our results using quantitative RT-P
CR showed that E-2 increased bcl-2 mRNA levels at 48 h of treatment via a t
ranscriptional mechanism. None of the hormone treatments altered the proapo
ptotic protein levels, bax and bak. We also studied the in vivo expression
of bcl-2 and other members of its family in biopsies of normal breast tissu
es according to the menstrual cycle. Bcl-2 displayed a strong cyclical vari
ation and seemed to be the most hormone-dependent member of the family. (C)
2000 Elsevier Science Inc. All rights reserved.